CONSULTING
Clinical and Professional Consulting Services
CLINICAL CONSULTING SERVICES
Dr Parker provides clinical consulting services for persons affected by hearing loss and/or their significant others. Contact him if you want individualized hearing healthcare delivered to you, if you have bothersome tinnitus, or if you have tried hearing aids in the past and they are in your drawer instead of your ear.
He would love to help you.
SERVICES for VETERANS
Dr Parker is an independent evaluator for the VA who provides Compensation and Pension (C & P) Examinations for US Veterans and current military personnel who are seeking a service-connected hearing loss and/or tinnitus disability. He is a subject matter expert in Noise Induced Hearing Loss, Hidden Hearing Loss, and Tinnitus.
Contact him of you would like to learn more about these examinations, particularly if your service-connected disability has been denied in the past..
PROFESSIONAL CONSULTING SERVICES
Dr Parker provides professional consulting services for businesses, venture capitalists, and other investment groups seeking an independent analysis of basic and clinical data related to the treatment of hearing loss.
Contact him if you want an independent analysis of public or private data related to conventional hearing aids and biological treatments for hearing loss such as drug, gene, and cell-based therapies.
PROFESSIONAL CONSULTING EXPERIENCE
2024-curr Audiology Consultant on an R21 “Role of connectivity between hippocampus/medial temporal lobe and auditory cortex in adverse listening conditions”
2023-curr: Subject Expert for an Over-the-Counter Hearing Aid manufacturer
2021-2022: Subject Expert for a Pharmaceutical company: clinical analysis of tinnitus side effects in internal clinical trial data
2021-curr: Technical Advisory Board Member for Lucid Hearing
2021: Subject Expert for a Venture Capital Group: clinical analysis of raw unpublished clinical trial data on hair cell regeneration
2021: Subject Expert for a Venture Capital Group A: clinical analysis of public clinical trial data on hair cell regeneration
2021: Subject Expert for a Venture Capital Group B: clinical analysis of public clinical trial data on hair cell regeneration
2021: Subject Expert for a Venture Capital Group C: clinical analysis of public clinical trial data on hair cell regeneration
2021: Subject Expert for a Venture Capital Group D: clinical analysis of public clinical trial data on hair cell regeneration
2021: Subject Expert for a Venture Capital Group E: clinical analysis of public clinical trial data on hair cell regeneration
2020: Subject Expert for a Venture Capital Group: hearing aid treatment for sensorineural hearing gloss
2019: Subject Expert for a Venture Capital Group A: drug therapy for hearing loss
2019: Subject Expert for a Venture Capital Group B: drug therapy for Meniere’s disease
2018: Subject Expert for a Venture Capital Group: drug treatment for hair cell regeneration
non-disclosure agreements prevent the identification of these companies.